ESC 2015 Schedule: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 32: Line 32:
* '''Interviewee:'''Dr. Luigi Di Biase
* '''Interviewee:'''Dr. Luigi Di Biase
* '''Topic:'''Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
* '''Topic:'''Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
* '''Embargo Lift:'''Sunday March 15, 2015 at 9:00AM
* '''Embargo Lift:'''Sunday August 30th, at 4:53 PM


=== 11:00 AM ===
=== 11:00 AM ===
* '''Interviewee:'''Dr. Marc Gillinov
''OPEN TIME SLOT''
* '''Topic:'''Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
* '''Embargo Lift:'''Monday March 16, 2015 at 8:15AM


=== 11:30 AM ===
=== 11:30 AM ''(PENDING)'' ===
* '''Interviewee:'''Dr. Rajeev K. Pathak
* '''Interviewee:'''Dr. Morris Brown
* '''Topic:'''Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
* '''Topic:'''''Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3''
* '''Embargo Lift:'''Monday March 16, 2015 at 8:30AM
* '''Embargo Lift:'''Monday August 31st at 5:16 PM


=== 12:00 PM ===
=== 12:00 PM ===
''OPEN TIME SLOT''


=== 12:30 PM ===
=== 12:30 PM ===
* '''Interviewee:'''Dr. Rino Sardella
''OPEN TIME SLOT''
* '''Topic:'''ACC 2015 Wrap-Up in Italian


=== 1:00 PM ===
=== 1:00 PM ===
* '''Interviewee:'''Dr. Hisao Ogawa
''OPEN TIME SLOT''
* '''Topic:'''ACC 2015 Wrap-Up in Japanese


=== 1:30 PM ===
=== 1:30 PM ===
* '''Interviewee:'''Dr. Susheel Kodali
''OPEN TIME SLOT''
* '''Topic:'''Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
* '''Embargo Lift:'''Sunday March 15, 2015 at 11:15AM


=== 2:00 PM ===
=== 2:00 PM ===
''OPEN TIME SLOT''


=== 2:30 PM ===
=== 2:30 PM ===
* '''Interviewee:'''Dr. Pamela S. Douglas
* '''Interviewee:''' Dr. Dirk Westermann
* '''Topic:'''A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
* '''Topic: '''Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:05AM
* '''Embargo Lift:''' Sunday, August 30th at 11:00 AM


=== 3:00 PM ===
=== 3:00 PM ===
* '''Interviewee:'''Dr. Marco Valgimigli
* '''Interviewee:'''Dr. Basil Lewis
* '''Topic:'''Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program'''&'''Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
* '''Topic: '''ESC 2015 Wrap-up in Hebrew
* '''Embargo Lift:'''Monday March 16, 2015 at 11:00AM'''&'''Monday March 16, 2015 at 11:15AM, respectively


=== 3:30 PM ===
=== 3:30 PM ===
* '''Interviewee:'''Dr. Marc Steven Sabatine
* '''Interviewee:'''Dr. Renato Lopes
* '''Topic:'''Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
* '''Topic:''' ESC 2015 Wrap-up in Portuguese
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively


=== 4:00 PM ===
=== 4:00 PM ===
* '''Interviewee:'''Dr. Roxana Mehran
* '''Interviewee:'''Pr. Freek Verheugt
* '''Topic:'''A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
* '''Topic: '''ESC 2015 Wrap-up from the Perspective of the Netherlands
* '''Embargo Lift:'''Sunday March 15, 2015 at 8:30AM


=== 4:30 PM ===
=== 4:30 PM ===
* '''Interviewee:'''Dr. Thomas Engstrøm
''OPEN TIME SLOT''
* '''Topic:'''The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
* '''Embargo Lift:'''Monday March 16, 2015 at 11:30AM


=== 5:00 PM ===
== Tuesday, September 1, 2015 ==
* '''Interviewee:'''Prof. Dr. Sigmund Silber
* '''Topic:'''ACC 2015 Wrap-Up in German
 
== Tuesday, March 17, 2015 ==


=== 8:00 AM ===
=== 8:00 AM ===
''OPEN TIME SLOT''


=== 8:30 AM ===
=== 8:30 AM ===
''OPEN TIME SLOT ''


=== 9:00 AM ===
=== 9:00 AM ===
''OPEN TIME SLOT ''


=== 9:30 AM ===
=== 9:30 AM ===
* '''Interviewee: '''Takeshi Kimura
* '''Topic: '''ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
* '''Embrago Lift: '''Tuesday, September 1st at 5:06 PM


=== 10:00 AM ===
=== 10:00 AM ===
* '''Interviewee:''' Gérard Helft
* '''Topic: '''The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
* '''Embargo Lift: '''Monday, August 31st at 12:12 PM


=== 10:30 AM ===
=== 10:30 AM ===
* '''Interviewee:''' Dr. Pamela Douglas
* '''Topic:''' Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
* '''Embargo Lift:''' Tuesday, September 1st at 4:30 PM


=== 11:00 AM ===
=== 11:00 AM ===
* '''Interviewee:''' Dr. Hisao Ogawa
* '''Topic: '''A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients '''AND '''ESC 2015 Wrap-up in''' '''Japanese
* '''Embargo Lift:''' Monday August 31st at 4:30 PM


=== 11:30 AM ===
=== 11:30 AM ===
''OPEN TIME SLOT''


=== 12:00 PM ===
=== 12:00 PM ===
''OPEN TIME SLOT''


=== 12:30 PM ===
=== 12:30 PM ===
''OPEN TIME SLOT''


=== 1:00 PM ===
=== 1:00 PM ===
* '''Interviewee:''' Dr. Gregg Stone
* '''Topic:''' Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
* '''Embargo Lift: '''Sunday, August 30th at 11:54 AM


=== 1:30 PM ===
=== 1:30 PM ===
* '''Interviewee:''' Dr. Patrick Serruys
* '''Topic: '''Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
* '''Embargo Lift: '''Tuesday, September 1st at 4:48 PM


=== 2:00 PM ===
=== 2:00 PM ===
* '''Interviewee: '''Dr. Gerasimos Filippatos
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
* '''Embargo Lift:''' Monday, August 31st at 11:18 AM


=== 2:30 PM ===
=== 2:30 PM ===
''OPEN TIME SLOT''


=== 3:00 PM ===
=== 3:00 PM ===
''OPEN TIME SLOT''


=== 3:30 PM ===
=== 3:30 PM ''(PENDING)'' ===
* '''Interviewee:''' Dr. Carlos A. Morillo
* '''Topic: '''The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
* '''Embargo Lift:''' Tuesday, September 1st at 12:08 PM


=== 4:00 PM ===
=== 4:00 PM ===
* '''Interviewee: '''Dr. Dr. Stefan James (and guest Dr. Jonas Oldgren)
* '''Topic: '''Wrap-up from a Scandinavian Perspective


=== 4:30 PM ===
=== 4:30 PM ''(PENDING)'' ===
* '''Interviewee: '''Gerasimos Filippatos
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
* '''Embrago Lift: '''Monday, August 31st at 11:18 AM
 
=== 5:00 PM - 6:00 PM ===
* Interviewee: Pr. Gilles Montalescot
* Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial '''AND''' Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study '''AND''' ESC 2015 Wrap-up in''' '''French
* Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) '''and '''Sunday, August 30th at 5:16 PM (AEGEAN)

Revision as of 15:52, 9 July 2015

Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.

Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom

Click on Date for Detailed Schedule

Monday, March 16, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

  • Interviewee:Dr. Vivek Reddy
  • Topic:Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
  • Embargo Lift: Sunday, August 30th at 5:38 PM

9:00 AM

OPEN TIME SLOT

9:30 AM

  • Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
  • Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
  • Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, august 30th at 4:30 PM

10:00 AM

  • Interviewee:Pr. Michel Ovize
  • Topic:Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
  • Embargo Lift: Sunday, August 30th, at 12:27 PM

10:30 AM (PENDING)

  • Interviewee:Dr. Luigi Di Biase
  • Topic:Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
  • Embargo Lift:Sunday August 30th, at 4:53 PM

11:00 AM

OPEN TIME SLOT

11:30 AM (PENDING)

  • Interviewee:Dr. Morris Brown
  • Topic:Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
  • Embargo Lift:Monday August 31st at 5:16 PM

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

OPEN TIME SLOT

2:30 PM

  • Interviewee: Dr. Dirk Westermann
  • Topic: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
  • Embargo Lift: Sunday, August 30th at 11:00 AM

3:00 PM

  • Interviewee:Dr. Basil Lewis
  • Topic: ESC 2015 Wrap-up in Hebrew

3:30 PM

  • Interviewee:Dr. Renato Lopes
  • Topic: ESC 2015 Wrap-up in Portuguese

4:00 PM

  • Interviewee:Pr. Freek Verheugt
  • Topic: ESC 2015 Wrap-up from the Perspective of the Netherlands

4:30 PM

OPEN TIME SLOT

Tuesday, September 1, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

  • Interviewee: Takeshi Kimura
  • Topic: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
  • Embrago Lift: Tuesday, September 1st at 5:06 PM

10:00 AM

  • Interviewee: Gérard Helft
  • Topic: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
  • Embargo Lift: Monday, August 31st at 12:12 PM

10:30 AM

  • Interviewee: Dr. Pamela Douglas
  • Topic: Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
  • Embargo Lift: Tuesday, September 1st at 4:30 PM

11:00 AM

  • Interviewee: Dr. Hisao Ogawa
  • Topic: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients AND ESC 2015 Wrap-up in Japanese
  • Embargo Lift: Monday August 31st at 4:30 PM

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

  • Interviewee: Dr. Gregg Stone
  • Topic: Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
  • Embargo Lift: Sunday, August 30th at 11:54 AM

1:30 PM

  • Interviewee: Dr. Patrick Serruys
  • Topic: Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
  • Embargo Lift: Tuesday, September 1st at 4:48 PM

2:00 PM

  • Interviewee: Dr. Gerasimos Filippatos
  • Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
  • Embargo Lift: Monday, August 31st at 11:18 AM

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM (PENDING)

  • Interviewee: Dr. Carlos A. Morillo
  • Topic: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
  • Embargo Lift: Tuesday, September 1st at 12:08 PM

4:00 PM

  • Interviewee: Dr. Dr. Stefan James (and guest Dr. Jonas Oldgren)
  • Topic: Wrap-up from a Scandinavian Perspective

4:30 PM (PENDING)

  • Interviewee: Gerasimos Filippatos
  • Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
  • Embrago Lift: Monday, August 31st at 11:18 AM

5:00 PM - 6:00 PM

  • Interviewee: Pr. Gilles Montalescot
  • Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial AND Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study AND ESC 2015 Wrap-up in French
  • Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) and Sunday, August 30th at 5:16 PM (AEGEAN)
Retrieved from "https://www.wikidoc.org/index.php?title=ESC_2015_Schedule&oldid=1117132"